60 Degrees Pharmaceuticals, Inc. SEC filings SXTP
60 Degrees Pharmaceuticals, Inc. has 222 filings in SEC EDGAR's recent list, going back to Oct 18, 2022. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 25, 2026 | — |
| DEL AM | Delaying amendment | Aug 17, 2026 | — |
| DEFR14A | Definitive proxy statement | Sep 2, 2025 | — |
| EFFECT | Filing | Jul 15, 2025 | — |
| CORRESP | Letter to the SEC | Jul 10, 2025 | — |
| CORRESP | Letter to the SEC | Jul 10, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2025 | — |
| DRS | Filing | Jun 6, 2025 | — |
| EFFECT | Filing | Apr 2, 2025 | — |
| CORRESP | Letter to the SEC | Mar 31, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 19, 2025 | — |
| D | Filing | Feb 12, 2025 | — |
| D | Filing | Feb 11, 2025 | — |
| EFFECT | Filing | Sep 30, 2024 | — |
| CORRESP | Letter to the SEC | Sep 26, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2024 | — |
| EFFECT | Filing | Jul 18, 2024 | — |
| CORRESP | Letter to the SEC | Jul 16, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 15, 2024 | — |
| EFFECT | Filing | Jan 29, 2024 | — |
| CORRESP | Letter to the SEC | Jan 26, 2024 | — |
| CORRESP | Letter to the SEC | Jan 26, 2024 | — |
| CORRESP | Letter to the SEC | Jan 26, 2024 | — |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| CORRESP | Letter to the SEC | Jan 22, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2024 | — |
| DRS | Filing | Jan 12, 2024 | — |
| NT 10-Q | Notification of late filing | Nov 15, 2023 | Sep 30, 2023 |
| CERT | Filing | Jul 12, 2023 | — |
| SEC STAFF LETTER | Filing | Jul 11, 2023 | — |
| EFFECT | Filing | Jul 11, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| CORRESP | Letter to the SEC | Jul 7, 2023 | — |
| CORRESP | Letter to the SEC | Jun 27, 2023 | — |
| 8-A12B/A | Fomr 8-a12b/a | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 27, 2023 | — |
| CORRESP | Letter to the SEC | Jun 22, 2023 | — |
| CORRESP | Letter to the SEC | Jun 16, 2023 | — |
| CORRESP | Letter to the SEC | Jun 16, 2023 | — |
| CORRESP | Letter to the SEC | Jun 14, 2023 | — |
| 8-A12B/A | Form 8-a12b/a | Jun 14, 2023 | — |
| 8-A12B | Form 8a-12b | Jun 14, 2023 | — |
| CORRESP | Letter to the SEC | Jun 12, 2023 | — |
| CORRESP | Letter to the SEC | Jun 12, 2023 | — |
| CORRESP | Letter to the SEC | Jun 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2023 | — |
| CORRESP | Letter to the SEC | Jun 1, 2023 | — |
| UPLOAD | Letter from the SEC | May 26, 2023 | — |
| D | Filing | May 24, 2023 | — |
| CORRESP | Letter to the SEC | May 19, 2023 | — |
| UPLOAD | Letter from the SEC | May 8, 2023 | — |
| CORRESP | Letter to the SEC | Apr 28, 2023 | — |
| SEC STAFF LETTER | Filing | Apr 14, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 14, 2023 | — |
| CORRESP | Letter to the SEC | Apr 3, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 8, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 6, 2023 | — |
| DRSLTR | Filing | Dec 23, 2022 | — |
| DRS/A | Filing | Dec 23, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 16, 2022 | — |
| DRSLTR | Filing | Dec 5, 2022 | — |
| DRS/A | Filing | Dec 5, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2022 | — |
| DRS | Filing | Oct 18, 2022 | — |
Showing 65 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SXTP (Nasdaq), SXTPW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Washington, DC
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1946563
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.